Wednesday 21st September 2022

Online

As competition for research funding increases, funding agencies are looking for novel ways to allocate their funds in a bid to remove potential biases and increase the transparency of how funding decisions are made. 

The overall goal of this event is to highlight examples from international funding entities that are either already piloting or considering implementing different models to allocate research funds, with a particular emphasis on the partial randomisation process, and highlight the perspective of researchers on this topic. The session will end with a roundtable discussion featuring the views from researchers hosted by Portuguese institutions on whether partial randomisation is an appropriate alternative to the current peer review process.  

Perspectives on the Partial Randomisation process

21st September 2022  Time (WEST) 

Chair: Ana Saraiva Ayash
Co-Chairs: Bruno Ceña, Filipa Cardoso, Andreia Tavares

9.30 - 9.45 am

Opening remarks
Leonor Beleza, President of the Champalimaud Foundation
Joana Lamego, Head of Strategic Research Development

9.45 - 10.15 am

Rethinking the funding line: random selection at the Swiss National Science Foundation 
Marco Bieri, Scientific Officer, Swiss National Science Foundation

10.15 - 10.45 am

Experimenting with grant awarding procedures
Lene Oddershede, Senior Vice President, Novo Nordisk Foundation

10.45 - 11.15 am 

The perspectives from researchers on funding lotteries
Axel Philipps, Leibniz Center for Science and Society, Leibniz University of Hannover

11.15 - 11.30 Comfort break

11.30 - 12.00 pm 

Canadian Institutes of Health Research – Equalization and Randomization
Adrian Mota, Associate Vice-President, Research Programs - Operations, Canadian Institutes of Health Research

12.00 - 1.15 pm 

Roundtable discussion: COLife Researchers views on partial randomisation for the allocation of research funding 

Moderated by Adriana Sánchez-Danés (ERA Chair), Champalimaud Foundation